ABLY MEDICAL AS

6005 ÅLESUND

Finances

Return on Equity

−31,82 %

Current Ratio

1,35

Debt-to-Equity Ratio

0,16

Key figures (NOK)	2022	2021	2020	2019
Revenue	7 638 000	16 798 000	13 339 000	2 958 000
Net Income	−11 548 000	−21 940 000	−7 238 000	−24 817 000
Total Assets	48 401 000	50 718 000	31 648 000	26 132 000
Total Equity	36 296 000	37 863 000	18 713 000	13 632 000

Income (NOK)	2022	2021	2020	2019
Revenue	7 638 000	16 798 000	13 339 000	2 958 000
Expenditure	18 335 000	38 394 000	20 099 000	27 496 000
Operating Profit	−10 697 000	−21 595 000	−6 760 000	−24 538 000
Financial Income	63 000	270 000	153 000	56 000
Financial Costs	913 000	615 000	631 000	335 000
Financial Balance	−850 000	−345 000	−478 000	−279 000
Earnings Before Tax	−11 548 000	−21 940 000	−7 238 000	−24 817 000
Tax	0	0	0	0
Net Income	−11 548 000	−21 940 000	−7 238 000	−24 817 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	39 731 000	24 422 000	24 619 000	17 107 000
Total Current Assets	8 670 000	26 297 000	7 029 000	9 025 000
Total Assets	48 401 000	50 718 000	31 648 000	26 132 000
Total Retained Equity	−11 593 000	0	0	11 576 000
Total Equity	36 296 000	37 863 000	18 713 000	13 632 000
Total Long-Term Debt	5 701 000	5 701 000	0	0
Total Current Debt	6 404 000	7 154 000	12 935 000	12 500 000
Total Equity and Debt	48 401 000	50 718 000	31 648 000	26 132 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	6 604 000	15 783 000	845 000	859 000
Other Income	1 035 000	1 015 000	12 493 000	2 099 000
Revenue	7 638 000	16 798 000	13 339 000	2 958 000
Cost of Goods Sold	0	0	0	0
Salary Costs	8 852 000	14 808 000	6 174 000	10 831 000
Depreciation	109 000	197 000	249 000	298 000
Impairment	0	0	0	0
Expenditure	18 335 000	38 394 000	20 099 000	27 496 000
Operating Profit	−10 697 000	−21 595 000	−6 760 000	−24 538 000
Financial Income	63 000	270 000	153 000	56 000
Financial Costs	913 000	615 000	631 000	335 000
Financial Balance	−850 000	−345 000	−478 000	−279 000
Dividends	0	0	0	0
Net Income	−11 548 000	−21 940 000	−7 238 000	−24 817 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	37 750 000	22 750 000	22 750 000	15 000 000
Real Eastate	63 000	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	136 000	239 000	436 000	685 000
Total Tangible Assets	199 000	239 000	436 000	685 000
Total Fiancial Fixed Assets	1 783 000	1 433 000	1 433 000	1 422 000
Total Fixed Assets	39 731 000	24 422 000	24 619 000	17 107 000
Stock	1 393 000	0	0	0
Total Investments	0	0	0	0
Cash, Bank	948 000	22 270 000	4 282 000	1 464 000
Total Current Assets	8 670 000	26 297 000	7 029 000	9 025 000
Total Assets	48 401 000	50 718 000	31 648 000	26 132 000
Total Equity	36 296 000	37 863 000	18 713 000	13 632 000
Short-Term Group Debt	0	0	23 000	0
Total Long-Term Debt	5 701 000	5 701 000	0	0
Creditors	2 216 000	2 506 000	1 212 000	3 462 000
Unpaid Taxes	862 000	1 108 000	787 000	906 000
Dividends	0	0	0	0
Other Current Debt	3 326 000	3 539 000	10 913 000	8 133 000
Total Current Debt	6 404 000	7 154 000	12 935 000	12 500 000
Total Equity and Debt	48 401 000	50 718 000	31 648 000	26 132 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−31,82 %	−57,95 %	−38,68 %	−182,05 %
Debt-to-Equity Ratio	0,16	0,15	0	0
Operating Profit Margin	−140,05 %	−128,56 %	−50,68 %	−829,55 %
Current Ratio	1,35	3,68	0,54	0,72
Quick Ratio	1,73	3,68	0,54	0,72
Equity Ratio	0,75	0,75	0,59	0,52
Gross Profit Margin	100 %	100 %	100 %	100 %